{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:04:07Z","timestamp":1794657847738,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["2373"],"award-info":[{"award-number":["2373"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1648-2","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T08:49:55Z","timestamp":1470214195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors"],"prefix":"10.1186","volume":"16","author":[{"given":"Erik","family":"Backhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Ockborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmir","family":"Nasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Trollfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"issue":"RR-8","key":"1648_CR1","first-page":"1","volume":"46","author":"CDC","year":"1997","unstructured":"CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1\u201324. Epub 1997\/04\/04.","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"1648_CR2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.yexcr.2010.03.003","volume":"316","author":"B Henriques-Normark","year":"2010","unstructured":"Henriques-Normark B, Normark S. Commensal pathogens, with a focus on Streptococcus pneumoniae, and interactions with the human host. Exp Cell Res. 2010;316(8):1408\u201314. Epub 2010\/03\/17.","journal-title":"Exp Cell Res"},{"issue":"3","key":"1648_CR3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","volume":"192","author":"MH Kyaw","year":"2005","unstructured":"Kyaw MH, Rose Jr CE, Fry AM, Singleton JA, Moore Z, Zell ER, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192(3):377\u201386. Epub 2005\/07\/05.","journal-title":"J Infect Dis"},{"issue":"1","key":"1648_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","volume":"65","author":"AJ Hoek van","year":"2012","unstructured":"van Hoek AJ, Andrews N, Waight PA, Stowe J, Gates P, George R, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect. 2012;65(1):17\u201324. Epub 2012\/03\/08.","journal-title":"J Infect"},{"issue":"2","key":"1648_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/clinids\/7.2.133","volume":"7","author":"LA Burman","year":"1985","unstructured":"Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis. 1985;7(2):133\u201342. Epub 1985\/03\/01.","journal-title":"Rev Infect Dis"},{"issue":"1","key":"1648_CR6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296\u2013327. Epub 2007\/12\/26.","journal-title":"Crit Care Med"},{"issue":"3","key":"1648_CR7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/315761","volume":"182","author":"B Henriques","year":"2000","unstructured":"Henriques B, Kalin M, Ortqvist A, Olsson Liljequist B, Almela M, Marrie TJ, et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis. 2000;182(3):833\u20139.","journal-title":"J Infect Dis"},{"issue":"3","key":"1648_CR8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/649872","volume":"50","author":"ZB Harboe","year":"2010","unstructured":"Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambertsen L, Kaltoft M, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis. 2010;50(3):329\u201337. Epub 2010\/01\/06.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1648_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/518538","volume":"45","author":"SR Alanee","year":"2007","unstructured":"Alanee SR, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis. 2007;45(1):46\u201351. Epub 2007\/06\/08.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1648_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1183\/09031936.01.00084401","volume":"18","author":"\u00c5 \u00d6rtqvist","year":"2001","unstructured":"\u00d6rtqvist \u00c5. Pneumococcal vaccination: current and future issues. Eur Respir J. 2001;18(1):184\u201395. Epub 2001\/08\/21.","journal-title":"Eur Respir J"},{"issue":"48","key":"1648_CR11","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","volume":"30","author":"NJ Andrews","year":"2012","unstructured":"Andrews NJ, Waight PA, George RC, Slack MP, Miller E. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine. 2012;30(48):6802\u20138. Epub 2012\/09\/25.","journal-title":"Vaccine"},{"issue":"11","key":"1648_CR12","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1086\/592970","volume":"47","author":"C Tsigrelis","year":"2008","unstructured":"Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study. Clin Infect Dis. 2008;47(11):1367\u201371. Epub 2008\/10\/24.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"1648_CR13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","volume":"348","author":"CG Whitney","year":"2003","unstructured":"Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737\u201346. Epub 2003\/05\/02.","journal-title":"N Engl J Med"},{"key":"1648_CR14","unstructured":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61(40):816-9. Epub 2012\/10\/12."},{"issue":"37","key":"1648_CR15","first-page":"822","volume":"63","author":"S Tomczyk","year":"2014","unstructured":"Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >\/=65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63(37):822\u20135. Epub 2014\/09\/19.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"1648_CR16","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.clinthera.2015.03.025","volume":"37","author":"KM Tromp","year":"2015","unstructured":"Tromp KM, Campbell MW, Vazquez A. Recent developments and future directions of pneumococcal vaccine recommendations. Clin Ther. 2015;37(5):928\u201334. Epub 2015\/04\/29.","journal-title":"Clin Ther"},{"key":"1648_CR17","volume-title":"Socialstyrelsens allm\u00e4nna r\u00e5d f\u00f6r vaccination mot pneumokocker","author":"SOSFS","year":"1994","unstructured":"SOSFS. Socialstyrelsens allm\u00e4nna r\u00e5d f\u00f6r vaccination mot pneumokocker. Stockholm: Socialstyrelsen; 1994."},{"issue":"9","key":"1648_CR18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/00365540110026818","volume":"33","author":"MS Dahl","year":"2001","unstructured":"Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A. Invasive pneumococcal infections in Southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis. 2001;33(9):667\u201372.","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"1648_CR19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc. 2010;85(10):933\u201342. Epub 2010\/08\/18.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1648_CR20","doi-asserted-by":"crossref","first-page":"276 e1","DOI":"10.1016\/j.amjmed.2005.07.044","volume":"119","author":"MH Kyaw","year":"2006","unstructured":"Kyaw MH, Holmes EM, Toolis F, Wayne B, Chalmers J, Jones IG, et al. Evaluation of severe infection and survival after splenectomy. Am J Med. 2006;119(3):276 e1\u20137. Epub 2006\/02\/24.","journal-title":"Am J Med"},{"issue":"4","key":"1648_CR21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ard.2010.133371","volume":"70","author":"M Neovius","year":"2011","unstructured":"Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis. 2011;70(4):624\u20139. Epub 2010\/12\/15.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1648_CR22","first-page":"685","volume":"27","author":"C Stahl-Hallengren","year":"2000","unstructured":"Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27(3):685\u201391. Epub 2000\/04\/01.","journal-title":"J Rheumatol"},{"issue":"5","key":"1648_CR23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/diacare.22.5.773","volume":"22","author":"B Berger","year":"1999","unstructured":"Berger B, Stenstrom G, Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care. 1999;22(5):773\u20138. Epub 1999\/05\/20.","journal-title":"Diabetes Care"},{"issue":"22","key":"1648_CR24","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113(22):5412\u20137. Epub 2009\/01\/31.","journal-title":"Blood"},{"key":"1648_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1465-9921-10-94","volume":"10","author":"J Lotvall","year":"2009","unstructured":"Lotvall J, Ekerljung L, Ronmark EP, Wennergren G, Linden A, Ronmark E, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res. 2009;10:94. Epub 2009\/10\/14.","journal-title":"Respir Res"},{"key":"1648_CR26","unstructured":"Altman DGM, David, TN Bryant, MJ Gardner. Statistics with Confidence. 2nd ed. London, UK: BMJ Books; 2000."},{"issue":"3","key":"1648_CR27","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","volume":"14","author":"DJ Isaacman","year":"2010","unstructured":"Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14(3):e197\u2013209. Epub 2009\/08\/25.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"1648_CR28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/379016","volume":"37","author":"MH Kyaw","year":"2003","unstructured":"Kyaw MH, Christie P, Clarke SC, Mooney JD, Ahmed S, Jones IG, et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis. 2003;37(10):1283\u201391. Epub 2003\/10\/30.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1648_CR29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1651-2227.2010.01748.x","volume":"99","author":"P Gessler","year":"2010","unstructured":"Gessler P, Martin F, Suter D, Berger C. Invasive pneumococcal disease in children prior to implementation of the conjugate vaccine in the Zurich region, Switzerland. Acta Paediatr. 2010;99(7):1005\u201310. Epub 2010\/03\/12.","journal-title":"Acta Paediatr"},{"issue":"6","key":"1648_CR30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jinf.2008.09.029","volume":"57","author":"N Ishiwada","year":"2008","unstructured":"Ishiwada N, Kurosaki T, Terashima I, Kohno Y. The incidence of pediatric invasive pneumococcal disease in Chiba prefecture, Japan (2003-2005). J Infect. 2008;57(6):455\u20138. Epub 2008\/10\/24.","journal-title":"J Infect"},{"issue":"6-7","key":"1648_CR31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/00365540500532852","volume":"38","author":"S Berg","year":"2006","unstructured":"Berg S, Trollfors B, Persson E, Backhaus E, Larsson P, Ek E, et al. Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis. 2006;38(6-7):427\u201332. Epub 2006\/06\/27.","journal-title":"Scand J Infect Dis"},{"issue":"16","key":"1648_CR32","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","volume":"297","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297(16):1784\u201392. Epub 2007\/04\/26.","journal-title":"JAMA"},{"issue":"11","key":"1648_CR33","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1086\/592972","volume":"47","author":"MR Jacobs","year":"2008","unstructured":"Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis. 2008;47(11):1388\u201395. Epub 2008\/10\/31.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1648_CR34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/jir052","volume":"203","author":"BW Beall","year":"2011","unstructured":"Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis. 2011;203(10):1360\u20138. Epub 2011\/03\/15.","journal-title":"J Infect Dis"},{"issue":"12","key":"1648_CR35","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1017\/S0950268810000919","volume":"138","author":"A Wong","year":"2010","unstructured":"Wong A, Marrie TJ, Garg S, Kellner JD, Tyrrell GJ. Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies. Epidemiol Infect. 2010;138(12):1804\u201310. Epub 2010\/05\/01.","journal-title":"Epidemiol Infect"},{"issue":"7","key":"1648_CR36","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1054\/bjoc.1999.1088","volume":"82","author":"JD Robertson","year":"2000","unstructured":"Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer. 2000;82(7):1261\u20135. Epub 2001\/02\/07.","journal-title":"Br J Cancer"},{"key":"1648_CR37","unstructured":"Mufson MA, Hao JB, Stanek RJ, Norton NB. Clinical Features of Patients With Recurrent Invasive Streptococcus pneumoniae Disease. Am J Med Sci. 2011. Epub 2011\/09\/22."},{"issue":"12","key":"1648_CR38","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2009.010066","volume":"94","author":"SY Kristinsson","year":"2009","unstructured":"Kristinsson SY, Bjorkholm M, Andersson TM, Eloranta S, Dickman PW, Goldin LR, et al. Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica. 2009;94(12):1714\u201320. Epub 2009\/07\/18.","journal-title":"Haematologica"},{"issue":"5","key":"1648_CR39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/319218","volume":"32","author":"MS Dworkin","year":"2001","unstructured":"Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis. 2001;32(5):794\u2013800. Epub 2001\/03\/07.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1648_CR40","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1086\/430356","volume":"191","author":"RT Heffernan","year":"2005","unstructured":"Heffernan RT, Barrett NL, Gallagher KM, Hadler JL, Harrison LH, Reingold AL, et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis. 2005;191(12):2038\u201345. Epub 2005\/05\/18.","journal-title":"J Infect Dis"},{"issue":"20","key":"1648_CR41","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","volume":"352","author":"TR Talbot","year":"2005","unstructured":"Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082\u201390. Epub 2005\/05\/20.","journal-title":"N Engl J Med"},{"issue":"34","key":"1648_CR42","first-page":"1102","volume":"59","author":"CDC","year":"2010","unstructured":"CDC. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59(34):1102\u20136. Epub 2010\/09\/04.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"1648_CR43","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MEG.0b013e3282f45764","volume":"20","author":"HJ Thomas","year":"2008","unstructured":"Thomas HJ, Wotton CJ, Yeates D, Ahmad T, Jewell DP, Goldacre MJ. Pneumococcal infection in patients with coeliac disease. Eur J Gastroenterol Hepatol. 2008;20(7):624\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"1648_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/ciq207","volume":"52","author":"DM Musher","year":"2011","unstructured":"Musher DM, Sampath R, Rodriguez-Barradas MC. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence? Clin Infect Dis. 2011;52(5):633\u201340. Epub 2011\/02\/05.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1648_CR45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.vaccine.2015.12.010","volume":"34","author":"BA Kendall","year":"2016","unstructured":"Kendall BA, Dascomb KK, Mehta RR, Stockmann C, Mason EO, Ampofo K, et al. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine. 2016;34(4):474\u20138. Epub 2015\/12\/27.","journal-title":"Vaccine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1648-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:51:38Z","timestamp":1498319498000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1648-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1648-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]},"article-number":"367"}}